Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872220 · ClinicalTrials.gov registry record · NA
To Test for Photo Allergy Reaction of Sunscreens
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT02872220: Completed NA study, sponsored by Bayer.
NCT02872220 is a NA study that has completed, run by Bayer. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02872220, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The primary objective of this tudy was to evaluate the potential of photoallergy of of sun care products Sun Protection Factor (SPF) 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 application compared to that of a negative control (0.9% sodium chloride, NaCl) and followed by irradiation with UV A and UVB. The secondary objective aims for evaluation of the safety of SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 combined with ultraviolet (UV) A/B irradiation by monitoring adverse events (AEs) throughout the study.
Primary Outcome
Inflammatory responses (Based on scores): 0 = No visible reaction + = Slight, confluent, or patchy erythema 1 = Mild erythema (pink) 2 = Moderate erythema (definite redness) 3 = Strong erythema (very intense redness)
Interventions
- DRUG SPF 50 Y65 110 (BAY987519)
- DRUG SPF 50 Y51 002 (BAY987519)
- DRUG SPF 15 V27 104 (BAY987519)
- DRUG Sodium chloride [NaCl]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2015-03-23 |
| Est. Completion | 2015-05-08 |
| Phase | NA |
What the finished NCT02872220 record still lists
NCT02872220 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which SPF 50 Y65 110 (BAY987519) is the first listed.
NCT02872220 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02872220 about?
NCT02872220 is a clinical study titled "To Test for Photo Allergy Reaction of Sunscreens". The primary objective of this tudy was to evaluate the potential of photoallergy of of sun care products Sun Protection Factor (SPF) 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 application compared to that of a negative control (0.9% sodium chloride, NaCl) and followed by irradiation with UV A an...
What is the current status of trial NCT02872220?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2015-03-23. Estimated completion is 2015-05-08.
What interventions are being tested in trial NCT02872220?
The interventions under investigation include: SPF 50 Y65 110 (BAY987519) (DRUG), SPF 50 Y51 002 (BAY987519) (DRUG), SPF 15 V27 104 (BAY987519) (DRUG), Sodium chloride [NaCl] (DRUG).
Who is sponsoring clinical trial NCT02872220?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02872220's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI